Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Annexon Inc
(NQ:
ANNX
)
5.070
-0.290 (-5.41%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,833,583
Open
5.320
Bid (Size)
5.070 (16)
Ask (Size)
5.270 (4)
Prev. Close
5.360
Today's Range
5.030 - 5.360
52wk Range
1.570 - 8.400
Shares Outstanding
47,722,995
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Annexon To Present Pivotal Phase 3 Data On Early And Durable Benefits With First-In-Class C1q Blocking Antibody ANX005 In Guillain-Barré Syndrome At 2024 PNS Annual Meeting
June 18, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
June 17, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Performance
YTD
+4.75%
+4.75%
1 Month
+8.33%
+8.33%
3 Month
-13.92%
-13.92%
6 Month
+76.04%
+76.04%
1 Year
+48.68%
+48.68%
More News
Read More
Annexon Announces Pricing of $125 Million Underwritten Public Offering
June 05, 2024
From
Annexon Biosciences
Via
GlobeNewswire
ANNX Stock Earnings: Annexon Beats EPS for Q1 2024
May 13, 2024
Via
InvestorPlace
DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 05, 2024
Via
Benzinga
Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
June 05, 2024
Via
Benzinga
Annexon Announces Proposed Public Offering of Common Stock
June 04, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Dow Surges 200 Points; Designer Brands Shares Plunge Following Q1 Earnings
June 04, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 04, 2024
Via
Benzinga
Mid-Cap Firm Annexon's Nerve Disorder Candidate Shows Promise In Pivotal Late-Stage Study
June 04, 2024
Via
Benzinga
Gold Down 1%; Bath & Body Works Shares Tumble After Q1 Results
June 04, 2024
Via
Benzinga
Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday
June 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 04, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 04, 2024
Via
InvestorPlace
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome
June 04, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
June 04, 2024
Via
Benzinga
Annexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 Data
June 03, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
May 16, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
May 13, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Biosciences to Present at the Bank of America Health Care Conference
May 09, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
May 07, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting
May 01, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
April 16, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Turnstone Biologics Appoints William Waddill to its Board of Directors
April 16, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.